Trends in Uterine Cancer Cases After the Coronavirus Disease 2019 (COVID-19) Pandemic

Obstet Gynecol. 2024 Dec 1;144(6):829-831. doi: 10.1097/AOG.0000000000005731. Epub 2024 Sep 19.

Abstract

We assessed the temporal trends in diagnosis of uterine cancer before and during the coronavirus disease 2019 (COVID-19) pandemic using data from the United States Cancer Statistics database spanning from 2001 to 2020. A comparison between projected and observed new cases in 2020 revealed a 4,232-case discrepancy, indicating 9.3% fewer diagnosed cases than predicted based on trends. Hispanic and Asian and Pacific Islander patients exhibited the highest discrepancy at 14.6% and 12.0% fewer cases, respectively, compared with 8.6% and 6.9% for White and Black patients. Our results highlight the importance of targeting health resources toward vulnerable populations in an effort to address accumulated cases of uterine cases after the pandemic.

MeSH terms

  • COVID-19* / epidemiology
  • Databases, Factual
  • Female
  • Humans
  • Pandemics
  • SARS-CoV-2
  • United States / epidemiology
  • Uterine Neoplasms* / epidemiology